TRAX — First Tracks Biotherapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $619.22m
- $619.22m
Annual balance sheet for First Tracks Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 385 | 312 |
| Prepaid Expenses | ||
| Total Current Assets | 390 | 316 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 16.2 | 13.9 |
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 442 | 331 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 36.2 | 31 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 50.3 | 43.1 |
| Common Stock | ||
| Other Equity | ||
| Total Equity | 392 | 287 |
| Total Liabilities & Shareholders' Equity | 442 | 331 |
| Total Common Shares Outstanding |